India's top court dismisses Novartis plea for Glivec patent
By Suchitra Mohanty and Kaustubh Kulkarni NEW DELHI/MUMBAI (Reuters) - India's top court has dismissed Swiss drugmaker Novartis AG's attempt to win patent protection for its cancer drug Glivec, a serious blow to Western pharmaceutical firms who are increasingly focusing on India to drive sales. The decision also sets a benchmark for several intellectual property disputes in India, where many patented drugs are unaffordable for most of its 1.2 billion people, 40 percent of whom earn less than $1.25 a day. ...
Source: news.yahoo.com
No comments:
Post a Comment